MH2 domain of Smad3 reduces HIV-1 Tat-induction of cytokine secretion

Journal of Neuroimmunology

Volumn 176, Issue 1-2, 2006, Pages 174-180

  Eldeen, Mazen B ^a   Deshmane, Satish L ^a   Simbiri, Kenneth ^a   Khalili, Kamel ^a   Amini, Shohreh ^a   Sawaya, Bassel E ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adeno MH2; Cytokines and chemokines production; HIV 1, Tat

Indexed keywords

CYTOKINE; SMAD3 PROTEIN; TRANSACTIVATOR PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADENOVIRUS; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; CELL MIGRATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE RELEASE; DOWNSTREAM PROCESSING; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INFLAMMATION; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADENOVIRIDAE; AIDS DEMENTIA COMPLEX; CHEMOKINE CCL2; CYTOKINES; GENE PRODUCTS, TAT; HIV-1; HUMANS; SMAD3 PROTEIN; U937 CELLS;

EID: 33746073006     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2006.04.004     Document Type: Article

References (45)

1. Abraham S., Sawaya B.E., Safak M., Batuman O., Khalili K., and Amini S. Regulation of MCP-1 gene transcription by Smads and HIV-1 Tat in human glial cells. Virology 309 (2003) 196-202
2. Abraham S., Sweet T., Sawaya B.E., Rappaport J., Khalili K., and Amini S. Cooperative interaction of C/EBP beta and Tat modulates MCP-1 gene transcription in astrocytes. J. Neuroimmunol. 160 (2005) 219-227
3. Amini S., Saunders M., Kelley K., Khalili K., and Sawaya B.E. Interplay between HIV-1 Vpr and Sp1 modulates p21(WAF1) gene expression in human astrocytes. J. Biol. Chem. 279 (2004) 46046-46056
4. Amini S., Mameli G., Del Valle L., Skowronska A., Reiss K., Gelman B.B., White M.K., Khalili K., and Sawaya B.E. p73 Interacts with human immunodeficiency virus type 1 Tat in astrocytic cells and prevents its acetylation on lysine 28. Mol. Cell. Biol. 25 (2005) 8126-8138
5. Ansari S.A., Safak M., Gallia G.L., Sawaya B.E., Amini S., and Khalili K. Interaction of YB-1 with human immunodeficiency virus type 1 Tat and TAR RNA modulates viral promoter activity. J. Gen. Virol. 80 (1999) 2629-2638
6. Bagasra O., Lavi E., Bobroski L., Khalili K., Pestaner J.P., Tawadros R., and Pomerantz R.J. Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry. AIDS 10 (1996) 573-585
7. Bayer P., Kraft M., Ejchart A., Westendorp M., Frank R., and Rosch P. Structural studies of HIV-1 Tat protein. J. Mol. Biol. 247 (1995) 529-535
8. Brady J., and Kashanchi F. Tat gets the "Green" light on transcription initiation. Retrovirology 2 (2005) 69
9. Buonaguro L., Barillari G., Chang H.K., Bohan C.A., Kao V., Morgan R., Gallo R.C., and Ensoli B. Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines. J. Virol. 66 (1992) 7159-7167
10. Demarchi F., d'Adda di Fagagna F., Falaschi A., and Giacca M. Activation of transcription factor NF-kappaB by the Tat protein of human immunodeficiency virus type 1. J. Virol. 70 (1996) 4427-4437
11. Dhawan S., Puri R.K., Kumar A., Duplan H., Masson J.M., and Aggarwal B.B. Human immunodeficiency virus-1-tat protein induces the cell surface expression of endothelial leukocyte adhesion molecule-1, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 in human endothelial cells. Blood 90 (1997) 1535-1544
12. El-Hage N., Wu G., Wang J., Ambati J., Knapp P.E., Reed J.L., Bruce-Keller A.J., and Hauser K.F. HIV-1 Tat and opiate-induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP-1 and alternative chemokines. Glia 53 (2005) 132-146
13. Gallia G.L., Darbinian N., Tretiakova A., Ansari S.A., Rappaport J., Brady J., Wortman M.J., Johnson E.M., and Khalili K. Association of HIV-1 Tat with the cellular protein, Puralpha, is mediated by RNA. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 11572-11577
14. Grande J.P. Role of transforming growth factor-beta in tissue injury and repair. Proc. Soc. Exp. Biol. Med. 214 (1997) 27-40
15. Gonzalez-Scarano F., and Martin-Garcia J. The neuropathogenesis of AIDS. Nat. Rev. Immunol. 5 (2005) 69-81
16. Gray F., Adle-Biassette H., Brion F., Ereau T., le Maner I., Levy V., and Corcket G. Neuronal apoptosis in human immunodeficiency virus infection. J. Neurovirology 6 Suppl 1 (2000) S38-S43
17. Husain S.R., Leland P., Aggarwal B.B., and Puri R.K. Transcriptional up-regulation of interleukin 4 receptors by human immunodeficiency virus type 1 tat gene. AIDS Res. Hum. Retroviruses 12 (1996) 1349-1359
18. Jeang K.T., Xiao H., and Rich E.A. Multifaceted activities of the HIV-1 transactivator of transcription. Tat. J. Biol. Chem. 274 (1999) 28837-28840
19. Kaul M., Garden G.A., and Lipton S.A. Pathways to neuronal injury and apoptosis in HIV associated dementia. Nature 410 (2001) 988-994
20. Kaul M., Zheng J., Okamoto S., Gendelman H.E., and Lipton S.A. HIV-1 infection and AIDS: consequences for the central nervous system. Cell Death Differ. 12 Suppl 1 (2005) 878-892
21. Kramer-Hammerle S., Rothenaigner I., Wolff H., Bell J.E., and Brack-Werner R. Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus. Virus Res. 111 (2005) 194-213
22. Langford D., and Masliah E. Crosstalk between components of the blood brain barrier and cells of the CNS in microglial activation in AIDS. Brain Pathol. 11 (2001) 306-312
23. Langford D., Grigorian A., Hurford R., Adame A., Crews L., and Masliah E. The role of mitochondrial alterations in the combined toxic effects of human immunodeficiency virus Tat protein and methamphetamine on calbindin positive-neurons. J. Neurovirology 10 (2004) 327-337
24. Liou L.Y., Herrmann C.H., and Rice A.P. HIV-1 infection and regulation of Tat function in macrophages. Int. J. Biochem. Cell Biol. 6 (2004) 1767-1775
25. Mastrangeli A., Danel C., Rosenfeld M.A., Stratford-Perricaudet L., Perricaudet M., Pavirani A., Lecocq J.P., and Crystal R.G. Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer. J. Clin. Invest. 91 (1993) 225-234
26. McArthur J.C., Sacktor N., and Selnes O. Human immunodeficiency virus-associated dementia. Semin. Neurol. 19 (1999) 129-150
27. Mishra L., Shetty K., Tang Y., Stuart A., and Byers S.W. The role of TGF-beta and Wnt signaling in gastrointestinal stem cells and cancer. Oncogene 24 (2005) 5775-5789
28. Nottet H.S., Flanagan E.M., Flanagan C.R., Gelbard H.A., Gendelman H.E., and Reinhard Jr. J.F. The regulation of quinolinic acid in human immunodeficiency virus-infected monocytes. J. Neurovirology 2 (1996) 111-117
29. Opalenik S.R., Shin J.T., Wehby J.N., Mahesh V.K., and Thompson J.A. The HIV-1 TAT protein induces the expression and extracellular appearance of acidic fibroblast growth factor. J. Biol. Chem. 270 (1995) 17457-17467
30. Perry S.W., Norman J.P., Litzburg A., Zhang D., Dewhurst S., and Gelbard H.A. HIV-1 transactivator of transcription protein induces mitochondrial hyperpolarization and synaptic stress leading to apoptosis. J. Immunol. 174 (2005) 4333-4344
31. Persidsky Y., Zheng J., Miller D., and Gendelman H.E. Mononuclear phagocytes mediate blood-brain barrier compromise and neuronal injury during HIV-1-associated dementia. J. Leukoc. Biol. 68 (2000) 413-422
32. Persidsky Y., Limoges J., Rasmussen J., Zheng J., Gearing A., and Gendelman H. Reduction in glial immunity and neuropathology by a PAF antagonist and an MMP and TNFalpha inhibitor in SCID mice with HIV-1 encephalitis. J. Neuroimmunol. 114 (2001) 57-68
33. Peruzzi F., Bergonzini V., Aprea S., Reiss K., Sawaya B.E., Rappaport J., Amini S., and Khalili K. Cross talk between growth factors and viral and cellular factors alters neuronal signaling pathways: implication for HIV-associated dementia. Brain Res. Rev. 50 (2005) 114-125
34. Petito C.K. Human immunodeficiency virus type 1 compartmentalization in the central nervous system. J. Neurovirology 10 Suppl 1 (2004) 21-24
35. Regulier E.G., Reiss K., Khalili K., Amini S., Rappaport J., Zagury J.F., and Katsikis P.D. T-cell and neuronal apoptosis in HIV infection: implications for therapeutic intervention. Int. Rev. Immunol. 23 (2004) 25-59
36. Sawaya B.E., Thatikunta P., Denisova L., Brady J., Khalili K., and Amini S. Regulation of TNFalpha and TGFbeta-1 gene transcription by HIV-1 Tat in CNS cells. J. Neuroimmunol. 87 (1998) 33-42
37. Sawaya B.E., Khalili K., Gordon J., Taube R., and Amini S. Cooperative interaction between HIV-1 regulatory proteins Tat and Vpr modulates transcription of the viral genome. J. Biol. Chem. 275 (2000) 35209-35214
38. Seoane J., Le H.V., Shen L., Anderson S.A., and Massague J. Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell 117 (2004) 211-223
39. Tahtinen M., Ranki A., Valle S.L., Ovod V., and Krohn K. B-cell epitopes in HIV-1 Tat and Rev proteins colocalize with T-cell epitopes and with functional domains. Biomed. Pharmacother. 51 (1997) 480-487
40. Toborek M., Lee Y.W., Pu H., Malecki A., Flora G., Garrido R., Hennig B., Bauer H.C., and Nath A. HIV-Tat protein induces oxidative and inflammatory pathways in brain endothelium. J. Neurochem. 84 (2003) 169-179
41. Toborek M., Lee Y.W., Flora G., Pu H., Andras I.E., Wylegala E., Hennig B., and Nath A. Mechanisms of the blood-brain barrier disruption in HIV-1 infection. Cell. Mol. Neurobiol. 25 (2005) 181-199
42. van Marle G., and Power C. Human immunodeficiency virus type 1 genetic diversity in the nervous system: evolutionary epiphenomenon or disease determinant?. J. Neurovirology 11 (2005) 107-128
43. Wallace D.R., Dodson S., Nath A., and Booze R.M. Estrogen attenuates gp120- and tat(1-72)-induced oxidative stress and prevents loss of dopamine transporter function. Synapse 59 (2006) 51-60
44. Watkins B.A., Dorn H.H., Kelly W.B., Armstrong R.C., Potts B.J., Michaels F., Kufta C.V., and Dubois-Dalcq M. Specific tropism of HIV-1 for microglial cells in primary human brain cultures. Science 249 (1990) 549-553
45. Westendorp M.O., Shatrov V.A., Schulze-Osthoff K., Frank R., Kraft M., Los M., Krammer P.H., Droge W., and Lehmann V. HIV-1 Tat potentiates TNF-induced NF-kappa B activation and cytotoxicity by altering the cellular redox state. EMBO J. 14 (1995) 546-554